2028年までの中南米脳腫瘍診断市場予測 - 診断タイプ別（画像検査、腰椎穿刺、生検、分子検査など）の新型コロナウイルス感染症の影響と地域分析。がんの種類（聴神経腫、星状細胞腫、頭蓋咽頭腫、神経節神経腫、多形膠芽腫、髄膜腫、上衣腫など）;エンドユーザー (病院、専門クリニック、外来手術センターなど)
市場紹介
脳がんは、腫瘍を引き起こす脳内の細胞の細胞外増殖によって引き起こされます。腫瘍には原発性脳腫瘍と続発性脳腫瘍が含まれます。原発性脳腫瘍は脳内で形成され、体の他の部分には広がりませんが、二次腫瘍（転移とも呼ばれます）は体の別の部分で発生したがんです。 脳腫瘍は 40 の主要なタイプに分類され、さらに 2 つの主要なグループに分類されます。1 つは良性、つまり成長が遅く転移する可能性が低いもの、悪性、つまり癌性で転移する可能性が高いものです。
< p>したがって、脳腫瘍の有病率の増加により、今後数年間で脳腫瘍診断に対する大きな需要が生み出されると予想され、それが脳腫瘍診断市場をさらに牽引すると予想されます。新型コロナウイルス？パンデミック19は、すでに過剰な負担と資金不足に陥っている中南米の公的医療制度にとって、重大な試練となっている。深刻な不平等に苦しんでいます。膨大な人口が貧困の中で暮らしている中南米では、過密、限られた衛生設備、食糧不安、予測不可能な環境条件などにより、広範な健康問題に継続的に直面している。資金不足の国営病院がこの地域の唯一の医療供給源です。ブラジルは新型コロナウイルス感染症の影響で危機的な状況にある。リソース不足がこの地域でさらなる課題を生み出し、脳腫瘍診断市場の成長を妨げています。これらすべての要因は、診断製品およびサービスの流通と採用を制限し、市場の成長を制限します。しかし、これらの国へのワクチン接種が続くにつれ、この地域のさまざまな市場関係者は再び脳腫瘍診断薬の開発に注力し始め、製品の流通量を増やすだろう。したがって、脳腫瘍診断市場に対するパンデミックの影響は緩和されるでしょう。
市場の概要とダイナミクス
中南米の脳腫瘍診断市場は、2021年の6,970万米ドルから2028年までに1億7,580万米ドルに成長すると予想されています。 2021 年から 2028 年までに 14.1% の CAGR で成長すると推定されています。「原発性脳腫瘍」という用語は、脳内で発生する腫瘍を指します。脳および神経系のがんは、男性および女性の死亡原因の第 10 位にあります。人の生涯において、この形態の腫瘍が発生する可能性は 1% 未満です。原発性中枢神経系 (CNS) 悪性腫瘍のほとんどは脳腫瘍であり、全症例の 85% ～ 90% を占めます。脳腫瘍は致命的となる可能性があり、生活の質に深刻な影響を及ぼし、最終的には患者とその家族の生活を一変させます。さらに、腫瘍の早期発見により、より多くの治療選択肢が得られることがよくあります。高度な画像技術により、脳腫瘍の位置を正確に特定できます。診断ツールには、磁気共鳴画像法 (MRI) およびコンピューター断層撮影 (CT または CAT スキャン) が含まれます。術中 MRI は、手術中の組織生検や腫瘍切除のガイドにも使用できます。磁気共鳴分光法 (MRS) は、腫瘍の化学的特徴を調べるために使用されます。したがって、脳腫瘍の有病率の増加により、脳腫瘍の診断ツールが強く求められています。
主要市場セグメント
診断の種類に関しては、画像検査セグメントが2020年の中南米脳腫瘍診断市場で最大のシェアを占めました。癌の種類に関しては、多形神経膠芽腫セグメントが中南米の脳で最大のシェアを占めました。 2020 年のがん診断市場。エンドユーザーの観点から見ると、2020 年の中南米脳がん診断市場では病院部門が最大のシェアを占めました。
リストされている主要な情報源と企業
準備のために参照されたいくつかの主要な一次および二次情報源中南米の脳腫瘍診断市場に関するこのレポートは、企業の Web サイト、年次報告書、財務報告書、政府文書、統計データベースなどです。このレポートに記載されている主要企業は、Thermo Fisher Scientific Inc.、Siemens Healthineers A、GE Healthcare、Biocept, Inc.、Koninklijke Philips NV、Canon Medical Systems、Hitachi, Ltd.、Neusoft Medical Systems です。
理由レポートを購入する
- 中南米の脳腫瘍診断市場の状況を理解し、最も成長する可能性が高い市場セグメントを特定する。強力なリターンを保証する
- 中南米の脳腫瘍診断市場の絶え間なく変化する競争環境を理解し、競争に先んじる
- 南部でのM&Aおよびパートナーシップ取引を効率的に計画する最も売上が見込まれる市場セグメントを特定することにより、中南米の脳腫瘍診断市場を対象とする
- 中南米の脳腫瘍診断市場のさまざまなセグメントの市場パフォーマンスの知覚的かつ包括的な分析から、知識に基づいたビジネス上の意思決定を行うのに役立ちます。
- 中南米地域の 2021 年から 2028 年までのさまざまなセグメントごとの市場収益予測を取得します。
中南米の脳腫瘍診断市場セグメンテーション
診断タイプ別
- 画像検査
- MRI
- CT スキャン
- PET
- 生検
- 分子検査
- 腰椎穿刺
- その他
がんの種類別
< ul>
作成者 エンド ユーザー
- 病院
- 専門クリニック
- 外来手術センター
- その他
国別
- 南および中央アメリカ
- ブラジル
- アルゼンチン
- その他の南および中央アメリカ
記載されている企業
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips NV
- Canon Medical Systems
- 株式会社日立製作所
- Neusoft Medical Systems
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type
1.3.2 Brain Cancer Diagnostics Market – By Cancer Type
1.3.3 Brain Cancer Diagnostics Market – By End User
1.3.4 South and Central America Brain Cancer Diagnostics Market – By Country
2. South and Central America Brain Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Brain Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Brain Cancer Diagnostics Market- South and Central America PEST Analysis
4.3 Expert Opinion
5. South and Central America Brain Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Brain Cancer
5.1.2 Rise in Number of Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Future Trends
5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery
5.4 Impact Analysis
6. Brain Cancer Diagnostics Market – South and Central America Analysis
6.1 South and Central America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis
7. South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type
7.1 Overview
7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
7.3 Imaging Tests
7.3.1 Overview
7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 MRI
7.3.3.1 Overview
7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 CT Scan
7.3.4.1 Overview
7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Positron emission tomography (PET)
7.3.5.1 Overview
7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lumbar Puncture
7.4.1 Overview
7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Biopsy
7.5.1 Overview
7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Molecular Testing
7.6.1 Overview
7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type
8.1 Overview
8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
8.3 Astrocytomas
8.3.1 Overview
8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Glioblastoma Multiforme
8.4.1 Overview
8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostics Market Analysis – By End user
9.1 Overview
9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 South and Central America: Brain Cancer Diagnostics Market
10.1.1 Overview
10.1.2 South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.2.1 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Brazil Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1.1 Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Argentina Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2 Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.5 Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on South and Central America Brain Cancer Diagnostics Market
11.1 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.1 Organic Developments
12.1.1 Overview
12.2 Inorganic Developments
12.2.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE Healthcare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Biocept, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips N.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Canon Medical Systems
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Hitachi, Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Neusoft Medical Systems
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments in the Brain Cancer Diagnostics Market
Table 14. Inorganic Developments in the Brain Cancer Diagnostics Market
Table 15. Glossary of Terms, Brain Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Brain Cancer Diagnostics Market Segmentation
Figure 2. South and Central America Brain Cancer Diagnostics Market Overview
Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market
Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Brain Cancer Diagnostics Market - South and Central America PEST Analysis
Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 7. South and Central America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. South and Central America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 29. Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
Figure 30. Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
Figure 31. Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in South and Central American Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips N.V
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America brain cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution